RESUMO
Sleep problems are highly prevalent among our children and adolescents. Its treatment is mainly based on cognitive behavioural therapies and habit modification procedures. However, the use of sleep promoting drugs and substances is widespread without being supported by clinical guidelines. Exogenous melatonin is a neurohormone marketed as a nutritional supplement that is being increasingly used in the management of sleep problems, and with no control over its use. The consensus document is presented on the use of melatonin in sleep-onset insomnia prepared by representatives of the Spanish Paediatric Association, the Spanish Society of Sleep, the Spanish Society of Paediatric Outpatients and Primary Care, the Spanish Society for Adolescent Medicine, the Spanish Society of Child Psychiatry, and the Spanish Society of Paediatric Neurology.
Assuntos
Hipnóticos e Sedativos/uso terapêutico , Melatonina/uso terapêutico , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Adolescente , Criança , HumanosAssuntos
Hiperlipidemias/diagnóstico , Adolescente , Fatores Etários , Criança , Pré-Escolar , Colesterol/sangue , Gorduras na Dieta/administração & dosagem , Feminino , Humanos , Hipercolesterolemia/dietoterapia , Hipercolesterolemia/epidemiologia , Hiperlipidemias/classificação , Hiperlipidemias/epidemiologia , Lipídeos/sangue , Lipoproteínas/sangue , Masculino , Valores de Referência , Fatores de Risco , Fatores Sexuais , Espanha/epidemiologiaRESUMO
The infant nutrition is surveyed on 1893 children of both sexes, aged from 0 to 18 years, in Fuenlabrada, Madrid. The percent of children with breast feeding has strongly decreased (47%) during the period 1965-1983, so its endurance has shortened (15%). The kind of feeding is related to the age mother and her smoking habit. The statistical correlation between the newborn intake and the cardiovascular risk factors is studied; no significant differences are found, excepting a temporary increase of the total cholesterol during the first quarter of life.